07:40 AM EST, 01/22/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) reported Q4 adjusted earnings Wednesday of $1.34 per diluted share, up from $1.19 a year earlier.

Net sales for the quarter ended Dec. 31 were $10.97 billion, compared with $10.24 billion a year earlier.

Analysts surveyed by FactSet expected $11.03 billion.

The company said it expects Q1 adjusted earnings of $1.05 to $1.09 per diluted share and fiscal 2025 adjusted earnings of $5.05 to $5.25 per diluted share.

Analysts surveyed by FactSet expect $5.16 for fiscal 2025 while the estimate for Q1 was not available.

Abbott Laboratories ( ABT ) shares were down more than 2% in recent Wednesday premarket activity.